Published in J Assoc Physicians India on February 01, 1969
Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med (2002) 6.94
Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med (1999) 5.02
Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India. BMJ (1998) 2.15
Kala-azar hits again. J Trop Med Hyg (1981) 1.68
Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis). Trans R Soc Trop Med Hyg (1984) 1.62
Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Bull World Health Organ (1998) 1.60
Socio-economics of visceral leishmaniasis in Bihar (India). Trans R Soc Trop Med Hyg (2000) 1.51
Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India. Clin Infect Dis (2003) 1.46
Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study. Clin Infect Dis (2003) 1.45
Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs. PLoS Negl Trop Dis (2011) 1.42
Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study. Am J Trop Med Hyg (2002) 1.31
Oral miltefosine for the treatment of Indian visceral leishmaniasis. Trans R Soc Trop Med Hyg (2006) 1.30
Comparison of regimens of treatment with sodium stibogluconate in kala-azar. Br Med J (Clin Res Ed) (1984) 1.27
Cold weather and myocardial infarction. Int J Cardiol (1987) 1.20
ECG changes in prolonged treatment of kala-azar with antimony compounds. J Assoc Physicians India (1988) 1.07
Full moon and crime. Br Med J (Clin Res Ed) (1985) 1.05
Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg (1999) 1.05
Leishmaniasis research - the challenges ahead. Indian J Med Res (2006) 1.01
Influence of milk, yoghurt and calcium on cholesterol-induced atherosclerosis in rabbits. Atherosclerosis (1981) 0.98
Newer strategies for the kala-azar elimination programme in India. Indian J Med Res (2009) 0.94
Correction of serum electrolyte imbalance prevents cardiac arrhythmia during amphotericin B administration. Natl Med J India (1995) 0.92
Harmful effect of high stibogluconate treatment of kala-azar in India. Trans R Soc Trop Med Hyg (1986) 0.85
Treatment of visceral leishmaniasis in Bihar. Trop Doct (1986) 0.85
ABO-blood groups in relation to ischaemic heart disease. Indian Heart J (1966) 0.85
Effect of Emblica officinalis on cholesterol-induced atherosclerosis in rabbits. Indian J Med Res (1984) 0.83
Emblica officinalis reduces serum, aortic and hepatic cholesterol in rabbits. Experientia (1985) 0.82
Study of the outbreak of kala-azar epidemic in Bihar. J Assoc Physicians India (1978) 0.82
Full moon and poisoning. Br Med J (1981) 0.81
Amphotericin B therapy in children with visceral leishmaniasis: daily vs. alternate day, a randomized trial. J Trop Pediatr (2010) 0.81
High concentration of adenosine in human visceral leishmaniasis despite increased ADA and decreased CD73. Parasite Immunol (2011) 0.80
Leishman-Donovan bodies in the duodenal mucosa of a child with kala-azar. Br Med J (Clin Res Ed) (1983) 0.78
Sodium antimony gluconate, amphotericin, and myocardial damage. Lancet (1998) 0.78
Successful treatment of resistant visceral leishmaniasis with liposomal amphotericin B. Trans R Soc Trop Med Hyg (1994) 0.77
Enrichment of invariant natural killer T cells in the bone marrow of visceral leishmaniasis patients. Parasite Immunol (2011) 0.76
Lymphatic leishmaniasis in India. J Assoc Physicians India (1993) 0.75
Successful conservative management of spontaneous intraperitoneal rupture of amebic liver abscess. A case report. Indian J Med Sci (1965) 0.75
An unusual case of angina pectoris with diffuse arterial calcification in a young male. Indian Heart J (1967) 0.75
Prohibition and alcohol intoxication. Br J Addict (1982) 0.75
The syndrome of ptosis, generalized muscular weakness and marked fasciculations of calf muscles due to insect bite. J Indian Med Assoc (1965) 0.75
Direct agglutination test for early diagnosis of Indian visceral leishmaniasis. J Assoc Physicians India (1996) 0.75
Influence of linseed oil on cholesterol-induced atherosclerosis in rabbits. Atherosclerosis (1979) 0.75
Relation between full moon & medicolegal deaths. Indian J Med Res (1987) 0.75
Clinical and laboratory comparison of different brands of amphotericin B used for the treatment of Kala-azar: an observational study. J Commun Dis (2008) 0.75
Epidemic dropsy with unusual features. Trop Doct (1983) 0.75
Influence of mustard oil on cholesterol-induced atherosclerosis in albino rabbits. Atherosclerosis (1981) 0.75
Relation of serum calcium with serum proteins in hypo-proteinaemic states. J Assoc Physicians India (1982) 0.75
Chemotherapy of leishmaniasis in India. Indian J Pediatr (1987) 0.75
Electrolyte excretion pattern of normal and hypertensive. Indian Heart J (1984) 0.75
Study of 250 cases of tropical eosinophilia. Indian J Chest Dis (1971) 0.75
Treatment of visceral leishmaniasis. J Assoc Physicians India (1985) 0.75
Treatment of kala-azar in India. Natl Med J India (1993) 0.75
Incidence of HIV infection in resistant cases of Indian kala-azar. J Assoc Physicians India (1994) 0.75
Egg protein and defatted soya protein on cholesterol induced hypercholesterolaemia and atherosclerosis in rabbits. Indian J Med Res (1982) 0.75
Controversy in the regimens of treatment with amphotericin B in resistant cases of kala-azar. J Assoc Physicians India (1995) 0.75
Studies of mortality from rheumatic heart disease. Indian Heart J (1969) 0.75
Missed cases of local tetanus. J Indian Med Assoc (1986) 0.75
Treatment for visceral leishmaniasis. J Assoc Physicians India (1987) 0.75
Effect of variation of temperature on the incidence of stroke. J Assoc Physicians India (1986) 0.75